Okuno, A, Tamemoto, H, Tobe, K, et al. (1998) Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101, 1354–1361.
Schoonjans, K, Peinado-Onsurbe, J, Lefebvre, AM, Heyman, RA, Briggs, M, Deeb, S, Staels, B & Auwerx, J (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15, 5336–5348.
Cohen, B, Novick, D & Rubinstein, M (1996) Modulation of insulin activities by leptin. Science 274, 1185–1188.
Miles, PD, Romeo, OM, Higo, K, Cohen, A, Rafaat, K & Olefsky, JM (1997) TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46, 1678–1683.
Maeda, N, Takahashi, M, Funahashi, T, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094–2099.
Yamauchi, T, Kamon, J, Waki, H, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941–946.
Dana, SL, Hoener, PA, Bilakovics, JM, Crombie, DL, Ogilvie, KM, Kauffman, RF, Mukherjee, R & Paterniti, JR Jr (2001) Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat. Metabolism 50, 963–971.
Wu, Z, Xie, Y, Morrison, RF, Bucher, NL & Farmer, SR (1998) PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 101, 22–32.
Park, KS, Ciaraldi, TP, Abrams-Carter, L, Mudaliar, S, Nikoulina, SE & Henry, RR (1997) PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46, 1230–1234.
Rieusset, J, Andreelli, F, Auboeuf, D, Roques, M, Vallier, P, Riou, JP, Auwerx, J, Laville, M & Vidal, H (1999) Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes 48, 699–705.
Vidal-Puig, AJ, Considine, RV, Jimenez-Linan, M, Werman, A, Pories, WJ, Caro, JF & Flier, JS (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99, 2416–2422.
Barroso, I, Gurnell, M, Crowley, VE, et al. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883.
Bergman, RN, Van Citters, GW, Mittelman, SD, Dea, MK, Hamilton-Wessler, M, Kim, SP & Ellmerer, M (2001) Central role of the adipocyte in the metabolic syndrome. J Investig Med 49, 119–126.
Kirkness, EF, Bafna, V, Halpern, AL, et al. (2003) The dog genome: survey sequencing and comparative analysis. Science 301, 1898–1903.
Bailhache, E, Ouguerram, K, Gayet, C, Krempf, M, Siliart, B, Magot, T & Nguyen, P (2003) An insulin-resistant hypertriglyceridaemic normotensive obese dog model: assessment of insulin resistance by the euglycaemic hyperinsulinaemic clamp in combination with the stable isotope technique. J Anim Physiol Anim Nutr 87, 86–95.
Iwase, M, Kimura, K, Komagome, R, Sasaki, N, Ishioka, K, Honjoh, T & Saito, M (2000) Sandwich enzyme-linked immunosorbent assay of canine leptin. J Vet Med Sci 62, 207–209.
Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔC T method. Methods 25, 402–408.
Young, PW, Cawthorne, MA, Coyle, PJ, Holder, JC, Holman, GD, Kozka, IJ, Kirkham, DM, Lister, CA & Smith, SA (1995) Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitozer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labelling. Diabetes 44, 1087–1092.
Zhang, B, Berger, J, Zhou, G, Elbrecht, A, Biswas, S, White-Carrington, S, Szalkowski, D & Moller, DE (1996) Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 271, 31771–31774.
Hu, E, Kim, JB, Sarraf, P & Spiegelman, BM (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274, 2100–2103.
Pamies-Andreu, E, Fiksen-Olsen, M, Rizza, RA & Romero, JC (1995) High-fructose feeding elicits insulin resistance without hypertension in normal mongrel dogs. Am J Hypertens 8, 732–738.
Rocchini, AP, Marker, P & Cervenka, T (1997) Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol 272 (1 Pt 1), E147–E154.
Kim, SP, Ellmerer, M, Van Citters, GW & Bergman, RN (2003) Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52, 2453–2460.
McAuley, K & Mann, J (2006) Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance. J Lipid Res 47, 1668–1676.
Peterson, KF, Befroy, D, Dufour, S, Dziura, J, Ariayan, C, Rothman, DL, DiPietro, L, Cline, GW & Shulman, GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 1140–1142.
Mingrone, G, Rosa, G, Di Rocco, P, Manco, M, Capristo, E, Castagneto, M, Vettor, R, Gasbarrini, G & Greco, AV (2002) Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 26, 1165–1172.
Kageyama, H, Hirano, T, Okada, K, Ebara, T, Kageyama, A, Murakami, T, Shioda, S & Adachi, M (2003) Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma. Biochem Biophys Res Commun 305, 22–27.
Montague, CT, Prins, JB, Sanders, L, Zhang, J, Sewter, CP, Digby, J, Byrne, CD & O'Rahilly, S (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47, 1384–1391.
Fujioka, S, Matsuzawa, Y, Tokunaga, K & Tarui, S (1987) Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36, 54–59.
Kelley, DE, Thaete, FL, Troost, F, Huwe, T & Goodpaster, BH (2000) Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol 278, E941–E948.
Norris, AW, Chen, L, Fisher, SJ, et al. (2003) Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest 112, 608–618.
Zierath, JR, Ryder, JW, Doebber, T, et al. (1998) Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action. Endocrinology 139, 5034–5041.
Eckel, RH (1989) Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320, 1060–1068. .
Bailhache, E, Nguyen, P, Krempf, M, Siliart, B, Magot, T & Ouguerram, K (2003) Lipoproteins abnormalities in obese insulin-resistant dogs. Metabolism 52, 559–564.
Preiss-Landl, K, Zimmermann, R, Hammerle, G & Zechner, R (2001) Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 13, 471–481.
Boucher, P, Ducluzeau, PH, Davelu, P, Andreelli, F, Vallier, P, Riou, JP, Laville, M & Vidal, H (2002) Expression and regulation by insulin of low-density lipoprotein receptor-related protein mRNA in human skeletal muscle. Biochim Biophys Acta 1588, 226–231.
Hill, MR, Young, MD, McCurdy, CM & Gimble, JM (1997) Decreased expression of murine PPARgamma in adipose tissue during endotoxemia. Endocrinology 138, 3073–3076.
Gayet, C, Bailhache, E, Dumon, H, Martin, L, Siliart, B & Nguyen, P (2004) Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity. J Anim Physiol Anim Nutr 88, 157–165.
De Vos, P, Lefebvre, AM, Miller, SG, Guerre-Millo, M, Wong, K, Saladin, R, Hamann, LG, Staels, B, Briggs, MR & Auwerx, J (1996) Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 98, 1004–1009.
Kallen, CB & Lazar, MA (1996) Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93, 5793–5796.
Arita, Y, Kihara, S, Ouchi, N, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79–83.
Lapsys, NM, Kriketos, AD, Lim-Fraser, M, Poynten, AM, Lowy, A, Furler, SM, Chisholm, DJ & Cooney, GJ (2000) Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab 85, 4293–4297.